AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Capital/Financing Update Jul 5, 2018

4924_rns_2018-07-05_db1f5998-46a2-4268-b396-767502983433.html

Capital/Financing Update

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6551T

Assura PLC

05 July 2018

5 July 2018

Assura plc

Trading Update

For the first quarter to 30 June 2018

Continued progress on deployment of capital 

Assura plc ("Assura"), the UK's leading primary care property investor and developer, today publishes a trading update for the first quarter to 30 June 2018.

Value enhancing investment and development activity

We continued to make progress in the first quarter, increasing the size of the pipeline by £73 million to £225 million, made up of acquisitions of £162 million and £63 million of developments.  In addition to growing the pipeline we completed the acquisition of six medical centres and two developments at a combined cost of £23.0 million.  The additions have a combined passing rent of £1.2 million and a weighted average unexpired lease length of 19.9 years.  

Rental income increased

Assura now owns 525 medical centres with a total annualised rent roll of £92.3 million (31 March 2018: £91.0 million), with growth in the financial year to date driven primarily by acquisitions.

Strong financial position

In the period we have agreed an additional £100 million unsecured revolving facility with Barclays Bank plc and HSBC plc on the same terms as the existing facility, taking our overall revolving facilities to £400 million.

As at 30 June 2018, gross debt stood at £510 million with undrawn facilities of £250 million.

Jonathan Murphy, CEO, commented:

"We have continued to deploy capital in the first quarter and identify new opportunities to grow the pipeline which can all be funded from current facilities.

We remain confident in the outlook for the year."  

- Ends -

For more information, please contact:

Assura plc Tel: 01925 420660
Jonathan Murphy

Jayne Cottam

Orla Ball
Edelman Tel: 0203 047 2546
John Kiely

Brett Jacobs

Rob Yates

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2018, Assura's property portfolio was valued at £1,733 million.

Further information is available at www.assuraplc.com 

*EPRA is a registered trademark of the European Public Real Estate Association 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TSTLFFILDVISIIT

Talk to a Data Expert

Have a question? We'll get back to you promptly.